HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Achim A Jungbluth Selected Research

Antigens

5/2022Cancer testis antigen (PRAME) as an independent marker for survival in oral squamous cell carcinoma (OSCC).
1/2022Expression Analysis of GD2 by Immunohistochemistry in Invasive Breast Carcinoma: Clinical and Pathologic Correlation.
12/2021Immunohistochemical Detection of Cancer-Testis Antigen PRAME.
6/2021PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions.
12/2020Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma.
4/2020Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder.
1/2020Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma.
1/2020Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
11/2019The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma.
1/2019Autologous Lymphocyte Infusion Supports Tumor Antigen Vaccine-Induced Immunity in Autologous Stem Cell Transplant for Multiple Myeloma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Achim A Jungbluth Research Topics

Disease

122Neoplasms (Cancer)
02/2022 - 02/2002
56Testicular Neoplasms (Testicular Cancer)
05/2022 - 02/2002
43Melanoma (Melanoma, Malignant)
01/2022 - 06/2002
20Carcinoma (Carcinomatosis)
12/2021 - 06/2002
13Breast Neoplasms (Breast Cancer)
01/2022 - 03/2003
12Sarcoma (Soft Tissue Sarcoma)
02/2022 - 06/2002
7Prostatic Neoplasms (Prostate Cancer)
11/2013 - 04/2007
7Neoplasm Metastasis (Metastasis)
08/2013 - 10/2002
6Multiple Myeloma
01/2019 - 07/2005
5Squamous Cell Carcinoma of Head and Neck
05/2022 - 05/2011
5Leiomyosarcoma
12/2021 - 01/2018
5Lung Neoplasms (Lung Cancer)
07/2015 - 03/2003
5Ovarian Neoplasms (Ovarian Cancer)
11/2013 - 09/2003
4Renal Cell Carcinoma (Grawitz Tumor)
10/2016 - 06/2002
4Glioma (Gliomas)
03/2011 - 03/2002
4Esophageal Neoplasms (Esophageal Cancer)
11/2008 - 03/2003
4Ovarian Epithelial Carcinoma
05/2008 - 09/2003
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 02/2007
3Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 08/2011
3Nevus (Nevi)
01/2020 - 10/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 03/2004
3Endometrioid Carcinoma
09/2017 - 01/2005
3Synovial Sarcoma (Synovioma)
01/2013 - 02/2002
3Colonic Neoplasms (Colon Cancer)
12/2011 - 07/2002
3Stomach Neoplasms (Stomach Cancer)
11/2006 - 11/2004
2Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 12/2017
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2020 - 10/2007
2Neuroblastoma
01/2018 - 04/2005
2Adenocarcinoma of Lung
01/2018 - 02/2007
2Thyroid Diseases (Thyroid Disease)
12/2017 - 10/2011
2Merkel Cell Carcinoma
01/2017 - 08/2015
2Endometrial Neoplasms (Endometrial Cancer)
01/2016 - 01/2005
2Disease Progression
11/2013 - 01/2013
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2013 - 09/2012
2Hypersensitivity (Allergy)
01/2013 - 07/2004
2Injection Site Reaction
12/2012 - 11/2008
2Urinary Bladder Neoplasms (Bladder Cancer)
02/2009 - 12/2003

Drug/Important Bio-Agent (IBA)

77AntigensIBA
05/2022 - 02/2002
38Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2002
23Monoclonal AntibodiesIBA
01/2022 - 02/2002
23VaccinesIBA
11/2019 - 10/2003
19Messenger RNA (mRNA)IBA
11/2019 - 06/2002
16AntibodiesIBA
01/2020 - 03/2002
13Neoplasm Antigens (Tumor Antigens)IBA
01/2019 - 07/2002
11Differentiation AntigensIBA
03/2016 - 10/2002
10RNA (Ribonucleic Acid)IBA
01/2021 - 10/2004
9Cancer VaccinesIBA
04/2020 - 10/2002
8MART-1 AntigenIBA
01/2022 - 10/2002
8Peptides (Polypeptides)IBA
03/2021 - 07/2007
7DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2014
7ParaffinIBA
01/2019 - 12/2003
6Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2009
6Indicators and Reagents (Reagents)IBA
01/2019 - 06/2002
6Monophenol Monooxygenase (Tyrosinase)IBA
03/2013 - 10/2002
5Phosphotransferases (Kinase)IBA
01/2018 - 02/2007
5IpilimumabIBA
01/2013 - 12/2008
5ErbB Receptors (EGF Receptor)IBA
03/2007 - 01/2003
5monoclonal antibody 806IBA
03/2007 - 03/2002
4Estrogen ReceptorsIBA
01/2022 - 05/2006
4Formaldehyde (Formol)FDA Link
10/2019 - 01/2005
4EnzymesIBA
12/2013 - 03/2004
4Complementary DNA (cDNA)IBA
02/2008 - 07/2002
3Hormones (Hormone)IBA
01/2022 - 03/2004
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2018
3DesminIBA
01/2021 - 01/2018
3Histones (Histone)IBA
10/2019 - 10/2002
3Progesterone Receptors (Progesterone Receptor)IBA
01/2018 - 08/2009
3arginine deiminaseIBA
12/2013 - 02/2012
3Monatide (IMS 3015)IBA
11/2013 - 05/2007
3Arginine (L-Arginine)FDA Link
04/2013 - 02/2012
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2012 - 02/2002
3EpitopesIBA
04/2007 - 07/2004
3epidermal growth factor receptor VIIIIBA
02/2007 - 03/2002
2Cathepsin KIBA
01/2022 - 11/2019
2B7-H1 AntigenIBA
01/2021 - 01/2020
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
11/2020 - 07/2015
2Biological ProductsIBA
11/2019 - 12/2017
2Immunoglobulin G (IgG)IBA
01/2018 - 07/2002
2ChromatinIBA
03/2017 - 01/2017
2Coloring Agents (Dyes)IBA
12/2016 - 03/2005
2poly ICLCIBA
11/2013 - 12/2012
2Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA
04/2013 - 01/2013
2AutoantigensIBA
12/2012 - 01/2008
2Tumor Biomarkers (Tumor Markers)IBA
08/2012 - 02/2009
2pullulanIBA
02/2012 - 04/2007
2CholesterolIBA
02/2012 - 04/2007
2CTLA-4 AntigenIBA
10/2011 - 12/2008
2Prostate-Specific Antigen (Semenogelase)IBA
02/2009 - 04/2007
2Recombinant ProteinsIBA
11/2008 - 03/2004
2Temozolomide (Temodar)FDA LinkGeneric
05/2008 - 12/2003
2Glycoproteins (Glycoprotein)IBA
02/2008 - 01/2006
2Membrane Proteins (Integral Membrane Proteins)IBA
11/2007 - 01/2006
2Histocompatibility Antigens Class IIBA
11/2007 - 03/2007

Therapy/Procedure

37Immunotherapy
02/2022 - 02/2002
27Therapeutics
01/2021 - 03/2002
9Drug Therapy (Chemotherapy)
11/2019 - 03/2004
3Stem Cell Transplantation
06/2014 - 02/2007
2Radioimmunotherapy
01/2018 - 12/2011
2Radiotherapy
04/2016 - 03/2012
2Hematopoietic Stem Cell Transplantation
06/2014 - 01/2013